Related Experiment Video
Updated: Jul 18, 2025

07:40
Digital Analysis of Immunostaining of ZW10 Interacting Protein in Human Lung Tissues
Published on: May 1, 2019
5.4K
A Multi-Stain Breast Cancer Histological Whole-Slide-Image Data Set from Routine Diagnostics
Philippe Weitz1, Masi Valkonen2, Leslie Solorzano3
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. philippe.weitz@ki.se.
Scientific Data
|August 24, 2023
Summary
This study introduces the largest public dataset of whole slide images (WSIs) for breast cancer, featuring matched hematoxylin and eosin (H&E) and immunohistochemistry (IHC) stains from the same tumors. This resource supports advancements in computational pathology for biomarker analysis.
Area of Science:
- Pathology
- Computational Biology
- Oncology
Background:
- Hematoxylin and eosin (H&E) and immunohistochemistry (IHC) staining of FFPE breast cancer tissue sections are crucial for pathological assessment.
- IHC is widely used for biomarker status (ER, PGR, HER2, KI67) in diagnostics.
- Computational pathology shows promise for biomarker assessment using whole slide images (WSIs).
Purpose of the Study:
- To address the scarcity of public data for computational pathology in breast cancer research.
- To create the largest publicly available dataset of matched H&E and IHC WSIs from primary breast cancer specimens.
Main Methods:
- Collected FFPE tissue sections from surgical resections of female primary breast cancer patients.
- Stained sections with H&E and various IHC markers.
- Acquired whole slide images (WSIs) for all stained sections.
- Matched WSIs from H&E and IHC stains from the same tumor tissue.
Main Results:
- Published the largest public dataset to date containing matched H&E and IHC WSIs.
- The dataset comprises 4,212 WSIs from 1,153 primary breast cancer patients.
- This dataset represents a significant resource for developing and validating computational pathology algorithms.
Conclusions:
- The newly released dataset significantly enhances the availability of high-quality, matched imaging data for breast cancer research.
- Facilitates the development of advanced computational tools for more accurate and efficient biomarker analysis.
- Aims to accelerate progress in precision medicine for breast cancer through improved image analysis techniques.

